S0139 HCPCS Level II code: Minoxidil, 10 mg
S0139 is the HCPCS code for “Minoxidil, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S0139Minoxidil, 10 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with S0139 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Added
- Apr 1, 2003
Where S0139 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S0139Minoxidil, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S0139 mean?
S0139 is the HCPCS code for “Minoxidil, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S0139?
CMS lists S0139’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S0139
All S codesS0126Injection, follitropin alfa, 75 iuS0128Injection, follitropin beta, 75 iuS0132Injection, ganirelix acetate, 250 mcgS0136Clozapine, 25 mgS0137Didanosine (ddi), 25 mgS0138Finasteride, 5 mgS0140Saquinavir, 200 mgS0142Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mgS0144Injection, propofol, 10 mgS0145Injection, pegylated interferon alfa-2a, 180 mcg per mlS0148Injection, pegylated interferon alfa-2b, 10 mcgS0155Sterile dilutant for epoprostenol, 50 ml